Credential Solutions™
Securely prove Trading Partner identities and licensing with W3C Verifiable Credentials issued by Legisym and backed by thorough, auditable due diligence in alignment with the Open Credentialing Initiative (OCI), the Partnership for DSCSA Governance (PDG), and DSCSA’s 2023 Authorized Trading Partner (ATP) requirements.
Digital Identities and Verifiable Credentials.
Issued by Legisym. backed by thorough, auditable due diligence.
As a regulatory compliance technology solution provider, Legisym is focused and experienced in both the highly DEA-regulated Controlled Substance Ordering System (CSOS) space and the complex nuisances and inconsistencies Trading Partners are met with when attempting to verify state-level licensing among the different Boards of Pharmacy.
With our existing achievements in Express222™ CSOS and License Verify™ technologies, it was a natural fit for Legisym to engage in the role of a Verifiable Credential Issuer. Through Credential Solutions™ we bring together the trust, security, and proper industry-supported due diligence processes required to successfully issue, monitor, and maintain digital identities and the verifiable credentials associated to them for DSCSA-related use cases and to bolster existing business interactions.
What are verifiable Credentials?
Why do I need them?
In a world of electronic exchanges with both direct and indirect relationships, it is hard to be certain if who you are interacting with is truly who they say they are AND that they have the proper authorization to interact and exchange information. A Verifiable Credential (VC), allows indirect trading partners like a manufacturer and a dispenser, to both prove
- they are who they say they are AND
- other sets of claims, such as their DSCSA Authorized Trading Partner (ATP) status,
in a secure and verifiable way EVEN if they have had no prior business relationship. Backed with a clear audit trail of the interaction.
How do I get them?
Credentials are obtained by seeking a trusted Credentials Issuer like Legisym, and completing a one-time due diligence onboarding process. When onboarding with Legisym, a user is guided through two simple onboarding screens where they, as an authorized representative of an organization, securely enter and upload the required information to prove identity and Authorized Trading Partner (ATP) status. This user is often an individual within the Administrative or internal Legal Team as they typically have the proper authority and access to corporate documentation and registrations. From there, the User’s effort is complete.
Depending on the verification method the user selected for verifying their identity and ATP status, the process for approval could take as little as 5 minutes.
Why Legisym?
Like many solution offerings, not all credentialing is equal and not every business model has the same needs. As a regulatory compliance technology solution provider with over a decade of experience, Legisym believes there is more to a successful partnership than a signed contract and an interoperable technical service solution. Behind that signature is a promise from our Business, Service, and Support Teams to provide the training, support, documentation, project management, and occasionally custom development, that allows us to efficiently and effectively deliver the kind of solution that will make a difference to your organization.
How Do I use them?
Similar to physical credentials like a birth certificate, passport, or state-issued driver’s license, you will need to store your Verifiable Credentials (VCs) in a secure location known as an OCI-aligned digital wallet. DSCSA solution providers, like Spherity, RxScan, Trust.Med, and LedgerDomain each provide software services for Trading Partners to manage their Legisym-issued VCs in a digital wallet that only you or those you allow have controlled and auditable access.
Once Legisym approves your request for a VC, Credential Solutions™ automatically issues the VC to your digital wallet where you have the power to provide your verification routing, track and trace, or other data management service providers with Provider API access. This allows your trusted provider to use your VCs in Saleable Returns verifications or to verify inbound VCs from other Trading Partners.
READY TO LEARN MORE?
Use the form below to learn more about Credential Solutions™ and partnership opportunities with Legisym.
Credentialing Community Resources
Keep Up with the latest in Credentialing
Explore the resources and educational materials below created by Legisym and other industry leaders within the Credentialing Community. As an OCI Founding Member and a Member of PDG, Legisym invites you to gain a deeper understanding of OCI’s architecture and PDG’s to maximize the use of the core components of Credentialing (Decentralized Identifiers, Verifiable Credentials, and the architecture and support services needed to manage them), for other DSCSA related use cases and to bolster existing business interactions.
Industry WorkGroups
Below are industry workgroups that Legisym actively participates in as a Credential Issuer. Through our membership, Legisym works with Standards organizations to standardize portions of the architecture, helps shepherd governance considerations based on our learnings as an Credential Issuer, aids others in learning and adopt the architecture, explores other uses for credentials, and contributes to the creation and enhancement of documents in an open environment.
OPEN CREDENTIALING INITIATIVE (OCI)
OCI is a collaborative, non-profit initiative formed by a group of trading partners, solution providers, and standards organizations to support the industry in adopting credentialing and digital wallet technologies. OCI establishes and maintains technical governance, specifications and guidelines in an open, trusted environment.
Partnership for DSCSA Governance (PDG)
A collaborative forum and FDA public-private partnership dedicated to developing, advancing, and sustaining an effective and efficient model for interoperable tracing and verification of prescription pharmaceuticals in the U.S.